Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

SABCS 2010: Interview with Klaus Pantel, M.D., Ph.D.

December 11, 2010 6:36 am | by AACR | News | Comments

Dr. Pantel discusses his findings about micrometastasis that contradict long-held beliefs about metastasis, and the implications of these discoveries for the treatment of breast cancer.

SABCS 2010: Interview with Edith A. Perez, M.D.

December 11, 2010 6:35 am | by AACR | News | Comments

In this podcast, Dr. Perez discusses ALTTO (the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), the role of genetic markers in breast cancer treatment, the challenges of treating patients with triple-negative breast cancer, and the promise of personalized medicine.

SABCS 2010: Interview with Charles M. Perou, Ph.D.

December 11, 2010 6:35 am | by AACR | News | Comments

Dr. Perou talks about genomic and genetic approaches to characterizing diverse breast cancers and their unique biologic features, using next-generation sequencing, and the implications of this science for clinical use.

Advertisement

SABCS 2010: Interview with Rochelle Shoretz

December 11, 2010 6:35 am | by AACR | News | Comments

Ms. Shoretz talks about the mission of Sharsheret, how she came to establish this nonprofit organization, and her appointment to a federal advisory committee on breast cancer in young women.

SABCS 2010: Interview with Sandi Stanford

December 11, 2010 6:34 am | by AACR | News | Comments

Ms. Stanford talks about the mission of the Alamo Breast Cancer Foundation and how advocates can take an active role in breast cancer research.

SABCS 2010: HER2 Teleconference

December 11, 2010 5:34 am | by AACR | News | Comments

Neil Spector, M.D., professor of medicine at Duke University Medical Center, hosts this press conference.

SABCS 2010: Circulating Tumor Cells and Metastasis Teleconference

December 11, 2010 5:34 am | by AACR | News | Comments

Minetta Liu, M.D., director of translational breast cancer research at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, hosts this press conference.

Maximizing the Potential of Multi-Drug Portfolios Without Cannibalizing from a Legacy Brand

December 10, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

CHAPEL HILL, N.C., Dec. 10, 2010 /- Managing multiple brands for the same indication is a complex balancing act for bio-pharmaceutical companies. While a new product can translate into expanded market share and improved reputation with physicians, it can also result in a new product...

Advertisement

SABCS 2010: Interview with Ivis Febus-Sampayo

December 10, 2010 7:35 am | by AACR | News | Comments

Ms. Febus-Sampayo discusses the cultural challenges faced by Latina women when they receive a cancer diagnosis, shares advice about how clinicians can best serve the Latina women who have cancer, and the long-term goals of her organization.

New Poll: Voters Want to Reduce Wasteful Spending in Medicaid Pharmacy

December 10, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Dec. 10, 2010 /PRNewswire-USNewswire/ -- Voters would rather reduce Medicaid spending by better managing pharmacy benefits rather than cutting benefits for patients or payments to doctors and hospitals, according to a new poll commissioned by the Pharmaceutical Care Management...

Advanced BioHealing Appoints Kevin C. O'Boyle as Chief Financial Officer

December 10, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

WESTPORT, Conn., Dec. 10, 2010 /- Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative medicine , today announced the appointment of Kevin C. O'Boyle, as Senior Vice President and Chief Financial Officer. (Photo:...

Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder

December 10, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Dec. 10, 2010 /- Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced today the pricing of the previously announced public offering of 2,000,000 shares of its common stock by Ares Corporate Opportunities Fund, L.P. at a public offering price of $20.00 per share.  The...

SABCS 2010: Interview with Carlos L. Arteaga, M.D.

December 10, 2010 7:34 am | by AACR | News | Comments

Dr. Arteaga discusses targeted drugs for breast cancer, endocrine resistance, clinical trial enrollment criteria and his reactions to some of the important presentations at this year's symposium.

Advertisement

SABCS 2010: Interview with Chi Van Dang, M.D., Ph.D.

December 10, 2010 7:34 am | by AACR | News | Comments

Dr. Dang discusses the major points of his plenary session, “Oncogenic Reprogramming of Metabolism and Therapy,” including how oncogenic alterations in cancers lead to altered tumor metabolism, and the function of the c-myc oncoprotein, which has emerged as a central oncogenic switch in...

SABCS 2010: Interview with Stacy L. Moulder, M.D.

December 10, 2010 7:33 am | by AACR | News | Comments

Dr. Moulder talks about her research on PARP inhibitors for hard-to-treat breast cancers, such as triple-negative breast cancer, and the collaborative team that continues this line of research.

SABCS 2010: Interview with George W. Sledge Jr., M.D.

December 10, 2010 7:33 am | by AACR | News | Comments

Dr. Sledge talks about the results of the first large nationwide study on the use of Taxol for advanced breast cancer, his perspective on new therapies for breast cancer, and his goals as president of the American Society of Clinical Oncology.

2010 SABCS: AZURE Trial Teleconference

December 10, 2010 6:32 am | by AACR | News | Comments

Robert E. Coleman, M.D., professor and honorary consultant medical oncologist at the Cancer Research Center, Academic Unit Medical of Clinical Oncology at Weston Park Hospital in Sheffield, England, presents the results of the AZURE (Adjuvant Zoledronic Acid to Reduce Recurrence) trial at...

2010 SABCS:Patient Screening and Management Teleconference Recording

December 9, 2010 9:34 am | by AACR | News | Comments

AACR President-elect Judy Garber, M.D., M.P.H., director of the Center for Cancer Genetics and Prevention at the Dana-Farber Cancer Institute, moderates this press conference.

Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium

December 9, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

BRIDGEWATER, N.J., Dec. 9, 2010 /- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today that the final survival analysis (10-year follow-up) of the BCIRG001 study that included a Taxotere® (docetaxel) Injection Concentrate chemotherapy treatment regimen in the adjuvant...

Ambry Genetics Launches Illumina HiSeq 2000 Next Generation Sequencing Services

December 9, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

ALISO VIEJO, Calif., Dec. 9, 2010 /- Ambry Genetics, a global leader in genomic services to the healthcare and life sciences industries, announced today that it has officially launched their Illumina HiSeq 2000 Next Generation Sequencing Services. Ambry Genetics has been an early adapter...

Caliper Life Sciences to Acquire Cambridge Research & Instrumentation

December 9, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

HOPKINTON and WOBURN, Mass., Dec. 9, 2010 /- Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research &...

Clarient Launches Insight® Dx Mammostrat® Breast Cancer Recurrence Test

December 9, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

ALISO VIEJO, Calif., Dec. 9, 2010 /- Clarient, Inc. (Nasdaq: CLRT ), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced the commercial launch of Mammostrat, a patented, novel test designed to help quantify the...

Assured Pharmacy, Inc. Receives Gross Proceeds of $300,000 from Sale of Convertible Debentures and Warrants

December 8, 2010 3:39 pm | by Bio-Medicine.Org | News | Comments

FRISCO, Texas, Dec. 8, 2010 /- Assured Pharmacy, Inc. (Pink Sheets: APHY ) (the "Company"), a growing chain of specialty pharmacies that provides advanced prescription services to a diverse array of medical professionals and their patients, announced today that it sold in a private...

Amgen to Present at Deutsche Bank's 2010 BioFEST

December 8, 2010 3:39 pm | by Bio-Medicine.Org | News | Comments

THOUSAND OAKS, Calif., Dec. 8, 2010 /- Amgen (Nasdaq: AMGN ) will participate in Deutsche Bank's 2010 BioFEST on Wednesday, Dec. 15, 2010, at the Four Seasons in Boston, beginning at 10:00 a.m. Eastern Time. Roy Baynes, M.D., Ph.D., vice president of Global Development and Arvind Sood,...

Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mechanism

December 8, 2010 3:39 pm | by Bio-Medicine.Org | News | Comments

EMERYVILLE, Calif., Dec. 8, 2010 /- Bionovo, Inc. (Nasdaq: BNVI ) today announced the publication of a study demonstrating that ERb causes cancer cell growth arrest by inactivating critical genes and enzymes responsible for cell growth. These results provide evidence that drugs that...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading